Newsroom

2018

Aug 27, 2018

Dr. Nandu Gattu, senior vice-president pharma analytics at Excelra, a biopharma data and analytics company, noted that osimertinib is significantly more expensive (estimated at three-10 times) than the first- and second-generation EGFR inhibitors and this may play as a key factor in clinical use. Read More…

May 16, 2018

Excelra and IIT-Kharagpur announce a multi-year collaboration aimed at accelerating research in Drug Repurposing. The alliance will leverage diverse skill-sets and domain expertise of the two partners and integrate Natural Language Processing (NLP) and Machine Learning (ML) technology in Excelra’s Drug Repurposing engine. Read More…

2017

November 13, 2017

Anandbir Singh Brar, CEO at EXCELRA was elated to talk on the development and noted, “Our collaboration has started gaining the momentum required to deliver unprecedented results. This is just the beginning. Read More…

2016

November 21, 2016

Based on its recent analysis of the biomarker research market, Frost & Sullivan recognizes Excelra Knowledge Solutions Pvt. Ltd. with the 2016 North American Frost & Sullivan Award for Enabling Technology Leadership. Excelra’s comprehensive, content-rich biomarker database. Read More…

July 19, 2016

Dr. Nandu Gattu heads the Pharma Analytics Group at Excelra. He has more than 25 years of experience in Computational Biology, Pharmacology and Drug Discovery & Development. Prior to joining Excelra, Dr. Gattu was associated with Schering Plough Pharmaceuticals, SmithKline Beecham, GlaxoSmithKline and Vimta Labs. Read More…

June 07, 2016

Excelra, Asia’s leading Knowledge Solutions Company today announced that it has entered into a strategic Drug Repurposing collaboration with Tokyo-based pharmaceutical company, Astellas Pharma Inc. The collaboration is focused on identifying novel therapeutic indications. Read More…

May 13, 2016

Excelra, Asia’s leading knowledge solutions company today announced its collaboration with H.M. Pharma Consultancy (HMPC), a life science consulting enterprise based in Austria, to jointly provide Drug repurposing services to Pharma and Biotech companies across Europe. Read More…

April 26, 2016

Excelra Knowledge Solutions today announced that it has extended its GOBIOM (Global Online Biomarker Database) license to the Biomarker Qualification Group of the USFDA. Excelra collaborated with the USFDA in the year 2008 in developing the safety biomarker content in GOBIOM. Read More…

Have a Question?